Lesbian, gay, bisexual, transgender, and queer (LGBTQ) youth (12-24 years) must navigate the typical challenges of adolescence while also managing the social stigma associated with their emerging sexual and gender minority identities. As a result, many LGBT youth are at higher risk for certain behavioral and emotional issues, homelessness, as well as bullying and other forms of victimization. This module discusses the unique health and developmental challenges of LGBT youth, and describes ways to address these issues in the clinical setting. Through sensitive, confidential communication with LGBT youth, clinicians can become a vital source of support for this vulnerable population.
This module aims to bring recognition to the presence of LGBT elders (age 65+), a group which is often overlooked. The module illustrates the unique medical, psychological, and social service needs of LGBT older adults, and gives recommendations for how clinicians can adequately address the needs of this group.
This module provides an overview of HIV incidence and prevalence in the United States, highlights groups most at risk for contracting HIV, describes the current state of HIV and STI screening, and explains biomedical and other interventions effective to curb the transmission of HIV. Using a case study, participants will be guided through effective screening and prevention methods, as well as communication strategies for talking to patients about their care.
American College of Physicians (ACP), 2015. Editors: Harvey Makadon, MD, Jennifer Potter, MD, Kenneth Mayer, MD and Hilary Goldhammer, MS of the Fenway Institute, Fenway Health
This new 2nd edition of The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health reflects clinical and social changes since the publication of the first edition.
- Filed under
- Introduction to LGBT Health
Human papilloma virus (HPV), one of the most common sexually transmitted infections, is preventable through a vaccine now recommended for all females and males age 11 to 26. However, vaccination rates remain low in the U.S., in part because only one-third of doctors prescribe the vaccine to eligible patients. HPV infection can lead to genital warts and certain types of cancer. This brief provides an analysis of the current state of HPV vaccination rates in the U.S., finding them lagging well behind other countries, where vaccination campaigns have been more successful.